(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

DIAGNOSTICS DEFINING THERAPY

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

DIAGNOSTICS DEFINING THERAPY

ST13

US500000079259148

Classe

1, 5, 10, 42, 44

Pedido

79259148

Registro

6039262

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

31

Atualização mais recente

29/04/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 10, 42, 44

Data de depósito

21/12/2018

Data de registro

28/04/2020

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

28/04/2020

Última transação

29/04/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

AU

Examinador

BUSH, KAREN

Unidade examinadora

L80

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

SpeeDx Pty Ltd

Representantes

Joi A. White Carr & Ferrell LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 10Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemicals used in industry, science, photography, agriculture, horticulture and forestry, except fungicides, herbicides, insecticides, and parasiticides; reagents and reactants for non-medical purposes; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acids for other than medical and veterinary purposes; acids, namely inorganic acids for industrial purposes; DNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring

Classe 5

Pharmaceutical and veterinary preparations and substances; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; enzymes for pharmaceutical, veterinary and medical purposes; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; clinical diagnostics for medical or veterinary use; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders

Classe 10

Surgical, medical and veterinary apparatus and instruments; diagnostic testing apparatus and instruments for medical purposes; diagnostic testing kits containing diagnostic testing apparatus; point of care medical devices; screening kits in this class comprised of medical screening and testing apparatus for the diagnosis of disease, detection and/or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy

Classe 42

Scientific and technological services and research and design relating thereto, namely, DNA analysis services for scientific research purposes, and scientific research consulting in the field of genetics; genetic research; genetic engineering services; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry services, namely, chemistry research services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of diagnostic apparatus for genetics research; design of diagnostic apparatus for genetics research; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, dna, rna, protein, polynucleic acid and molecular analysis and evaluation services; dna and rna and polynucleic acid and protein sequencing, analysis and evaluation services; genome sequencing services and the analysis and evaluation of data resulting therefrom; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services; custom design and development of biochemical assays; molecular diagnostics testing

Classe 44

Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services relating to dna, genetics and genetic testing; medical diagnostic services in the nature of medical testing and medical analysis; providing collected and analysed medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; diagnostic imaging for medical purposes and molecular medicine healthcare services

Publicações

Histórico de despachos e eventos da marca no USPTO.

31 publicações encontradas

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

28/04/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/08/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/08/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/08/2022

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

13/08/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

26/09/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/09/2020

FIMP

FINAL DISPOSITION PROCESSED

31/08/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

28/07/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

28/04/2020

GPNX

NOTIFICATION PROCESSED BY IB

14/02/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/02/2020

PUBO

PUBLISHED FOR OPPOSITION

11/02/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

29/01/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

29/01/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

22/01/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/01/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

19/12/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

19/12/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

18/12/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

17/12/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

17/12/2019

RFNT

REFUSAL PROCESSED BY IB

12/07/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

24/06/2019

RFRR

REFUSAL PROCESSED BY MPU

24/06/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/06/2019

CNRT

NON-FINAL ACTION WRITTEN

04/06/2019

MAFR

APPLICATION FILING RECEIPT MAILED

01/06/2019

DOCK

ASSIGNED TO EXAMINER

28/05/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

28/05/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

23/05/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace DIAGNOSTICS DEFINING THERAPY ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.